Improving HPV uptake in school leavers living in areas of high deprivation

TENDER DESCRIPTION

The HPV vaccine remains one of the most effective vaccines, providing long-lasting protection against several strains of the human papillomavirus that is known to cause cervical, vaginal, vulval, anal, penile, and head/neck cancers. A single dose of the vaccine is offered to boys and girls aged 12-13 years old through the School Aged Immunisation Service (SAIS). With the COVID-19 pandemic causing significant disruptions to delivery, resulting in a reduction in overall coverage, uptake rates have failed to recover to pre-pandemic levels. There is increasing evidence that HPV uptake is lower among socio-economically deprived groups, with lower coverage associated with lower IMD among older adolescents in the initial catch-up programme that was delivered in schools and other settings between 2008-2011. Catch-up campaigns, including the GP HPV campaign, provide individuals who missed the routine offer with an additional opportunity to be vaccinated. Capturing learning from these campaigns and associated activities is essential to identify effective approaches, inform future delivery models, and determine what further action may be required to reduce inequalities in uptake. This…

TENDER BRIEF

TENDER DOCUMENTS